Free tool
Cell therapy stocks
We cover 22 companies grouped under the Cell therapy theme. The median market value in the group is $18.87M. Across the group, the median move over the past trading day is +0.06%. 23% of the 22 with a 200-day average trade above it. Price change over the past year runs from −86.2% to −13.4% across the middle 80 percent of the group, with a median of −55.4%.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
22 of 86 companies match these filters.Clear filters
| Ticker | Company | Price | 1M return | YTD return | 1Y return |
|---|---|---|---|---|---|
| ATRA | Atara Biotherapeutics, Inc. | $9.84 | +27.63% | −44.63% | −19.61% |
| ACET | Adicet Bio, Inc. | $9.00 | +11.66% | +2.04% | −20.89% |
| INKT | MiNK Therapeutics, Inc. | $11.38 | +7.46% | +2.34% | −21.89% |
| ALPS | Alps Group Inc | $0.31 | −32.74% | −65.44% | −87.70% |
| TCRX | TScan Therapeutics, Inc. | $0.79 | +3.35% | −22.19% | −58.23% |
| TVGN | Tevogen Inc. | $6.97 | +25.13% | −61.70% | −84.85% |
| DTSQ | DT Cloud Star Acquisition Corporation | $11.33 | −0.18% | +4.72% | +8.42% |
| CCEL | Cryo-Cell International, Inc. | $4.30 | +30.30% | +25.36% | −0.92% |
| ESLA | Estrella Immunopharma, Inc. | $0.73 | −5.48% | −47.30% | −24.41% |
| LGVN | Longeveron Inc. | $0.68 | +11.29% | +14.67% | −12.71% |
| NCEL | NewcelX Ltd. | $3.48 | −3.33% | +66.51% | −85.80% |
| PLUR | Pluri Inc. | $1.56 | −4.88% | −47.83% | −71.43% |
| BCDA | BioCardia, Inc. | $1.13 | +39.51% | −11.02% | −42.05% |
| SNTI | Senti Biosciences Holdings, Inc. | $0.39 | +4.52% | −64.46% | −75.42% |
| INAB | IN8bio, Inc. | $1.17 | −1.68% | −52.44% | −46.58% |
| GDTC | CytoMed Therapeutics Limited | $0.94 | +3.89% | −32.73% | −52.59% |
| FBLG | FibroBiologics, Inc. | $1.40 | +123.29% | −70.83% | −88.54% |
| CELZ | Creative Medical Technology Holdings, Inc. | $1.24 | +56.31% | −37.06% | −61.19% |
| ERNA | Ernexa Therapeutics Inc. | $4.93 | +25.64% | −83.02% | −86.22% |
| PMCB | PharmaCyte Biotech, Inc. | $0.53 | −10.26% | −28.86% | −48.78% |
| BRTX | BioRestorative Therapies, Inc. | $0.22 | −19.68% | −81.76% | −85.26% |
| MBIO | Mustang Bio, Inc. | $0.55 | −1.43% | −48.41% | −64.16% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.